Top Clinical Trials companies in Israel by Total Assets

This ranking features the top 38 Clinical Trials companies in Israel ranked by Total Assets, totaling a Total Assets of USD 41.68 B, for July 06, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Clinical Trials company in Israel has the highest Total Assets ?

The Clinical Trials company in Israel with the highest Total Assets is Teva Pharmaceutical Industries Limited (Tel Aviv Stock Exchange: TEVA.TA) at USD 39.33 B.

Which Clinical Trials company in Israel has the lowest Total Assets ?

The Clinical Trials company in Israel with the lowest Total Assets is Nextgen Biomed Ltd (Tel Aviv Stock Exchange: NXGN.TA) at None.

What are the top 10 Clinical Trials companies in Israel by Total Assets ?

The top 10 Clinical Trials companies in Israel by Total Assets are Teva Pharmaceutical Industries Limited, InMode Ltd., Kamada Ltd., Ilex Medical Ltd, InterCure Ltd., Compugen Ltd., SHL Telemedicine Ltd., BrainsWay Ltd., MediWound Ltd. and InspireMD, Inc..

What are the bottom 10 Clinical Trials companies in Israel by Total Assets ?

The bottom 10 Clinical Trials companies in Israel by Total Assets are Nextgen Biomed Ltd, Kadimastem Ltd, NeuroSense Therapeutics Ltd., Entera Bio Ltd., Allmed Solutions Ltd, Bonus BioGroup Ltd., Alpha Tau Medical Ltd., Epitomee Medical Ltd, Can-Fite BioPharma Ltd. and Nextage Therapeutics Ltd.